NantWorks

Biotech billionaire Soon-Shiong picks up rights to CytRx’s troubled cancer drug
Endpoints
Fri, 07/28/17 - 11:33 am
biotech
Dr. Patrick Soon-Shiong
CytRx
NantCell
NantWorks
doxorubicin
soft tissue sarcoma
4 US pharma execs make Forbes 400 list
BioPharma Dive
Wed, 10/19/16 - 06:47 pm
Patrick Soon-Shiong
NantWorks
Phillip Frost
OPKO Health
Randal Kirk
Intrexon
Robert Duggan
Pharmacyclics